Cystic Fibrosis Foundation - 08 Dec 2022 Form 3 Insider Report for Aridis Pharmaceuticals, Inc.

Role
10%+ Owner
Signature
/s/ Irena Barisic, Chief Operating and Financial Officer
Issuer symbol
ARDS on OTC
Transactions as of
08 Dec 2022
Net transactions value
$0
Form type
3
Filing time
19 Dec 2022, 05:05:09 UTC
Next filing
26 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARDS Common Stock, par value $0.0001 per share 5,168,732 08 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.